Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 578-583

  Von Landenberg, Philipp ^a   Döring, Yvonne ^a   Modrow, Susanne ^b   Lackner, Karl J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Antiphospholipid antibodies; Infection associated autoimmunity; Parvovirus B19

Indexed keywords

AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY;

ARTHRALGIA; AUTOIMMUNE DISEASE; BLOOD CELL; CONFERENCE PAPER; CONNECTIVE TISSUE; ENCEPHALITIS; ERYTHEMA INFECTIOSUM; FETUS HYDROPS; FLU LIKE SYNDROME; HEPATITIS; HUMAN; IMMUNE RESPONSE; INFECTION; JOINT; LEUKOPENIA; MENINGITIS; MOLECULAR MIMICRY; MYOCARDITIS; NONHUMAN; PARVOVIRUS; PATHOPHYSIOLOGY; PURE RED CELL ANEMIA; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; UVEA; VIRUS INFECTION;

PARVOVIRUS;

EID: 34948821749     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.060     Document Type: Conference Paper

References (37)

1. HUGHES, G., N. HARRIS & A. GHARAVI. 1986. The anticardiolipin syndrome. J. Rheumatol. 13: 486-489.
2. HARRIS, E., A. GHARAVI, M. BOEY, et al. 1983. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 26: 1211-1214.
3. MCNEIL, H., R. SIMPSON, C. CHESTERMAN, et al. 1990. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I apolipoprotein H. Proc. Natl. Acad. Sci. USA 87: 4120-4124.
4. MATSUURA, E., Y. IGARASHI, M. FUJIMOTO, et al. 1992. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148: 3885-3891.
5. SHOENFELD, Y., A. GHARAVI & T. KOIKE. 1998. β2GP-I in the antiphospholipid Hughes' syndrome - from a cofactor to an autoantigen - from induction to prevention of antiphospholipid syndrome. Lupus 7: 503-506.
6. GHARAVI, A., L. SAMMARITANO, J. WEN, et al. 1992. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I apolipoprotein H. J. Clin. Invest. 90: 1105-1109.
7. BLANK, M., D. FADEN, A. TINCANI, et al. 1994. Immunization with anticardiolipin cofactor beta-2-glycoprotein I induces experimental antiphospholipid syndrome in naive mice. J. Autoimmun. 7: 441-455.
8. GEORGE, J., M. BLANK, Y. LEVY, et al. 1998. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 97: 900-906.
9. LOIZOU, S., M. WALPORT & K. DAVIES. 1996. The antiphospholipid syndrome in infectious diseases. In The Antiphospholipid Syndrome. R. ASHERSON, R. CERVERA, J.C. PIETTE & Y. SHOENFELD, Eds.: 267-284. CRC Press Inc. Andover, United Kingdom.
10. PURI, V., A. BOOKMAN, E. YEO, et al. 1999. Antiphospholipid antibody syndrome associated with hepatitis C infection. J. Rheumatol. 26: 509-510.
11. YANEZ, A., L. CEDILLO, O. NEYROLLES, et al. 1999. Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome. Emerg. Infect. Dis. 5: 164-167.
12. HAYEM, G., N. KASSIS, P. NICAISE, et al. 1999. Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever: a possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy- coagulopathy. Arthritis Rheum. 42: 1056-1061.
13. SHOENFELD, Y., M. BLANK & I. KRAUSE. 2000. The relationship of antiphospholipid antibodies to infections - do they bind to infecting agents or may they even be induced by them. Clin. Exp. Rheumatol. 18: 431-432.
14. ASHERSON, R., R. CERVERA, J. PIETTE, et al. 2001. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Balti.) 80: 355-377.
15. BLANK, M., I. KRAUSE, M. FRIDKIN, et al. 2002. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109: 797-804.
16. OLDSTONE, M. 1998. Molecular mimicry and immune-mediated diseases. FASEB J. 12: 1255-1265.
17. KARLSEN, A. & T. DYRBERG. 1998. Molecular mimicry between nonself, modified self and self in autoimmunity. Semin. Immunol. 10: 25-34.
18. ALBERT, L., R. INMAN. 1999. Molecular mimicry and autoimmunity. N. Engl. J. Med. 341: 2068-2074.
19. BLANK, M., R. ASHERSON, R. CERVERA, et al. 2004. Antiphospholipid syndrome infectious origin. J. Clin. Immunol. 24: 12-23.
20. ASHERSON, R., G. ESPINOSA, R. CERVERA, et al. 2005. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann. Rheum. Dis. 64: 943-946.
21. VON LANDENBERG, P., H. LEHMANN, A. KNOLL, et al. 2003. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum. 48: 1939-1947.
22. COSSART, Y., B. CANT, A. FIELD, et al. 1975. Parvovirus-like particles in human sera. Lancet 1: 72-73.
23. ANDERSON, M., S. JONES, S. FISHER-H OCH, et al. 1983. The human parvovirus, the cause of erythema infectiosum fifth disease? Lancet 1: 1378.
24. ANDERSON, M., P. HIGGINS, L. DAVIS, et al. 1985. Experimental parvoviral infection in humans. J. Infect. Dis. 152: 257-265.
25. ANDERSON, M., L. DAVIS, D. HODGSON, et al. 1982. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J. Clin. Pathol. 357: 744.
26. BÜLTMANN, B., K. KLINGEL, K. SOTLAR, et al. 2003. Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch. 54: 498-500.
27. CASSINOTTI, P., S. BAS, G. SIEGL, et al. 1995. Association between 396 human parvovirus B19 infection and arthritis. Ann. Rheum. Dis. 54: 498-500.
28. GUILLAUME, M., N. HERMANUS & A. PERETZ. 2002. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection. Clin. Rheumatol. 21: 306-308.
29. CERVERA, R., J. PIETTE, J. FONT, et al. 2002. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 46: 1019-1027.
30. LOIZOU, S., J. CAZABON, M. WALPORT, et al. 1997. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 40: 103-108.
31. LUNARDI, C., M. TISO, L. BORGATO, et al. 1998. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur. J. Immunol. 28: 936-948.
32. SEKINE, T., T. KATO, K. MASUKO-HONGO, et al. 1999. Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis. Ann. Rheum. Dis. 58: 446-450.
33. LU, J., N. ZHI, S. WONG, et al. 2006. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J. Infect. Dis. 193: 582-590.
34. SERRA, C., S. RODRIGUES, N. SILVA, et al. 1999. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 17: 375-380.
35. REITBLAT, T., T. DROGENIKOV, I. SIGALOV, et al. 2000. Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection. Am. J. Med. 109: 512.
36. BLANK, M, I. KRAUSE, M. FRIDKIN, et al. 2002. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. Clin. Invest. 109: 797-804.
37. GHARAVI, A., S. PIERANGELI, R. ESPINOLA, et al. 2002. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum. 46: 545-552.